Albumin from Cynomolgus Monkey

<strong>Albumin from Cynomolgus Monkey</strong>_x000D_ <strong>Catalog number:</strong> B2015306_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 500 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Albumin, Cynomolgus Monkey_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Ulrichts P, Guglietta A, Dreier T, van Bragt T, Hanssens V, Hofman E, Vankerckhoven B, Verheesen P, Ongenae N, Lykhopiy V, Enriquez FJ, Cho J, Ober RJ, Ward ES, de Haard H, Leupin N. Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans J Clin Invest. 2018 Oct 1;128(10):4372-4386._x000D_ 2: Smith B, Kiessling A, Lledo-Garcia R, Dixon KL, Christodoulou L, Catley MC, Atherfold P, D'Hooghe LE, Finney H, Greenslade K, Hailu H, Kevorkian L, Lightwood D, Meier C, Munro R, Qureshi O, Sarkar K, Shaw SP, Tewari R, Turner A, Tyson K, West S, Shaw S, Brennan FR. Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration MAbs. 2018 Oct;10(7):1111-1130._x000D_ 3: Coelho T, Adams D, Silva A, Lozeron P, Hawkins PN, Mant T, Perez J, Chiesa J, Warrington S, Tranter E, Munisamy M, Falzone R, Harrop J, Cehelsky J, Bettencourt BR, Geissler M, Butler JS, Sehgal A, Meyers RE, Chen Q, Borland T, Hutabarat RM, Clausen VA, Alvarez R, Fitzgerald K, Gamba-Vitalo C, Nochur SV, Vaishnaw AK, Sah DW, Gollob JA, Suhr OB. Safety and efficacy of RNAi therapy for transthyretin amyloidosis N Engl J Med. 2013 Aug 29;369(9):819-29._x000D_ 4: Steiner D, Merz FW, Sonderegger I, Gulotti-Georgieva M, Villemagne D, Phillips DJ, Forrer P, Stumpp MT, Zitt C, Binz HK. Half-life extension using serum albumin-binding DARPin® domains Protein Eng Des Sel. 2017 Sep 1;30(9):583-591._x000D_ 5: Latvala S, Jacobsen B, Otteneder MB, Herrmann A, Kronenberg S. Distribution of FcRn Across Species and Tissues J Histochem Cytochem. 2017 Jun;65(6):321-333._x000D_ 6: Fuchs H, Chen LZ, Low S, Yu H. Ocular and systemic pharmacokinetics of BI-X, a nanobody targeting VEGF and Ang-2, after intravitreal dosing in cynomolgus monkeys - Evidence for half-life extension by albumin Exp Eye Res. 2021 Apr;205:108486._x000D_ 7: Toris CB, Pederson JE, Tsuboi S, Gregerson DS, Rice TJ. Extravascular albumin concentration of the uvea Invest Ophthalmol Vis Sci. 1990 Jan;31(1):43-53._x000D_ 8: Gayrard V, Alvinerie M, Toutain PL. Interspecies variations of corticosteroid-binding globulin parameters Domest Anim Endocrinol. 1996 Jan;13(1):35-45._x000D_ 9: Zhao Y, Liu G, Angeles A, Hamuro LL, Trouba KJ, Wang B, Pillutla RC, DeSilva BS, Arnold ME, Shen JX. Development and validation of a liquid chromatography tandem mass spectrometry assay for the quantitation of a protein therapeutic in cynomolgus monkey serum J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Apr 15;988:81-7._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/3335204">10: Bourget C, Femino A, Franz C, Longcope C. Estrogen and androgen dynamics in the cynomolgus monkey Endocrinology. 1988 Jan;122(1):202-6. </a>_x000D_ _x000D_ <strong>Products Related to Albumin from Cynomolgus Monkey can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>